Clinical trial · Observational
Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion
NCT05693727CI-TRIAL-00063384not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the ability of cancer ratio and pleural fluid markers to discriminate between malignant and non malignant effusion
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pleural Effusion, Malignant | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| pleural markers | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Differentiate between malignant and non malignant pleural effusion by pleural markers
- timeFrame
- Baseline
- description
- using pleural markers
Secondary outcomes (1)
- measure
- Time saving
- timeFrame
- Baseline
- description
- decrease the need for invasive maneuvers for diagnosis * decrease length of hospital stay * decrease the development of complications
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients (100 cases) with exudative pleural effusion who will be admitted to Department of Chest diseases and Tuberculosis, Assiut University Hospital Exclusion Criteria: * Age ˂ 18 years * Refusal to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.